Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 53
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Pituitary ; 24(6): 970-977, 2021 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-34518998

RESUMEN

PURPOSE: We present an up-to-date review of all published cases of sellar melanocytoma, a benign melanocytic neoplasm arising from melanocytes present in the leptomeninges surrounding the pituitary. METHODS: Both the Medline and Embase databases were searched for case reports or case series of patients with a sellar mass consisting of melanocytes. RESULTS: All 14 identified patients developed symptoms due to compression of the surrounding structures. Symptoms included pituitary dysfunction and visual impairment. All patients received a transsphenoidal resection as first-line treatment. The diagnosis is made on pathological examination but deciding whether a sellar melanocytic tumor is best classified as a melanocytoma or a melanoma is not straightforward. DISCUSSION: Genetic analyses can help differentiate between central nervous system origin and metastasis of a cutaneous melanoma with the presence of a GNAQ and GNA11 mutations or a BRAF mutation, respectively. First choice treatment is complete resection, and in case of incomplete resection or recurrence additional radiotherapy is advised.


Asunto(s)
Melanoma , Neoplasias Cutáneas , Humanos , Melanocitos , Mutación , Hipófisis
2.
J Neurooncol ; 146(1): 55-62, 2020 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-31701343

RESUMEN

INTRODUCTION: Quantitative methylation specific PCR (qMSP) is a frequently used technique to assess MGMT gene promoter methylation in glioblastoma patients. The optimal technical cut-off value to distinguish methylated from unmethylated samples is nevertheless still undetermined. In literature, a "grey zone" of diagnostic uncertainty has been described. METHODS: We performed a retrospective analysis of newly diagnosed glioblastoma patients treated according to the Stupp protocol. Epidemiological data were gathered from the individual patient files. MGMT gene promoter methylation status was determined on stored tumour samples using qMSP. A strong, weak or absent promoter methylation was determined based on Cq values (quantification value) of the MGMT and ACTB primers as well as a positive control sample. RESULTS: In total, 181 patient files were reviewed and included for statistical analysis. MGMT promoter hypermethylation was detected in 38.7% of glioblastoma patients. The median overall survival of unmethylated and strongly methylated patients was 10.1 months and 19.7 months respectively. Furthermore, 11% of the total patient cohort had a weak MGMT gene promoter methylation. The median OS in this subgroup was 15.4 months, significantly better compared to the unmethylated cohort (P < 0.001). Multivariate Cox regression analysis showed weak MGMT promoter methylation as an independent prognostic parameter for overall survival. CONCLUSION: Glioblastoma patients with weak promoter methylation show a statistically significant longer overall survival when compared to clearly unmethylated patients. Patients with grey zone qMSP test results should receive additional molecular analysis in future to further direct individual therapy strategies.


Asunto(s)
Biomarcadores de Tumor/genética , Neoplasias Encefálicas/mortalidad , Metilación de ADN , Metilasas de Modificación del ADN/genética , Enzimas Reparadoras del ADN/genética , Regulación Neoplásica de la Expresión Génica , Glioblastoma/mortalidad , Proteínas Supresoras de Tumor/genética , Anciano , Antineoplásicos Alquilantes/uso terapéutico , Neoplasias Encefálicas/genética , Neoplasias Encefálicas/patología , Neoplasias Encefálicas/terapia , Quimioradioterapia/mortalidad , Terapia Combinada , Femenino , Estudios de Seguimiento , Glioblastoma/genética , Glioblastoma/patología , Glioblastoma/terapia , Humanos , Masculino , Persona de Mediana Edad , Pronóstico , Regiones Promotoras Genéticas , Estudios Retrospectivos , Tasa de Supervivencia , Temozolomida/uso terapéutico
3.
Br J Surg ; 105(7): 885-892, 2018 06.
Artículo en Inglés | MEDLINE | ID: mdl-29623678

RESUMEN

BACKGROUND: The number of transmen seeking gender-confirming surgery has risen steadily throughout the last decade. Pathologists are increasingly confronted with transmale mastectomy specimens. It is not clear whether routine histopathological examination is useful. This study explored the possible benefit of routine investigation through detailed description of lesions encountered in mastectomy specimens after female-to-male gender-confirming surgery. METHODS: Breast tissue from a cohort of transmen was reviewed. The presence of benign and malignant breast lesions was recorded. The number of terminal duct-lobule units (TDLUs) per ten low-power fields (LPFs) was quantified. Information on hormone therapy and morphometry was retrieved for selected patients. RESULTS: The cohort included 344 subjects with a mean age of 25·8 (range 16-61) years at the time of surgery; the age at surgery decreased significantly over time. Older individuals presented with a significantly higher number of breast lesions. The number of TDLUs per LPF was lower in heavier breasts, but did not correlate with age. Breast lesions, either benign or malignant, were present in 166 individuals (48·3 per cent). Invasive breast cancer was found in two (0·6 per cent); one tumour was an unexpected finding. The number of breast lesions encountered on histopathological examination increased significantly when more tissue blocks were taken. CONCLUSION: The discovery of an unexpected breast cancer in a 31-year-old transman emphasizes the importance of thorough routine histopathological examination of mastectomy specimens. The number of tissue blocks taken should be based on age and breast weight.


Asunto(s)
Mama/patología , Mastectomía , Cirugía de Reasignación de Sexo/métodos , Transexualidad/cirugía , Adolescente , Adulto , Factores de Edad , Mama/cirugía , Neoplasias de la Mama/patología , Femenino , Disforia de Género/cirugía , Humanos , Masculino , Persona de Mediana Edad , Tamaño de los Órganos , Factores de Riesgo , Transexualidad/patología , Adulto Joven
4.
Nat Genet ; 28(2): 131-8, 2001 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-11381259

RESUMEN

Hypoxia stimulates angiogenesis through the binding of hypoxia-inducible factors to the hypoxia-response element in the vascular endothelial growth factor (Vegf) promotor. Here, we report that deletion of the hypoxia-response element in the Vegf promotor reduced hypoxic Vegf expression in the spinal cord and caused adult-onset progressive motor neuron degeneration, reminiscent of amyotrophic lateral sclerosis. The neurodegeneration seemed to be due to reduced neural vascular perfusion. In addition, Vegf165 promoted survival of motor neurons during hypoxia through binding to Vegf receptor 2 and neuropilin 1. Acute ischemia is known to cause nonselective neuronal death. Our results indicate that chronic vascular insufficiency and, possibly, insufficient Vegf-dependent neuroprotection lead to the select degeneration of motor neurons.


Asunto(s)
Hipoxia de la Célula/genética , Factores de Crecimiento Endotelial/genética , Linfocinas/genética , Neuronas Motoras/patología , Degeneración Nerviosa/genética , Elementos de Respuesta/genética , Esclerosis Amiotrófica Lateral/genética , Esclerosis Amiotrófica Lateral/patología , Animales , Axones/fisiología , Sitios de Unión , Electrofisiología , Factores de Crecimiento Endotelial/metabolismo , Humanos , Linfocinas/metabolismo , Ratones , Ratones Noqueados , Neuronas Motoras/fisiología , Contracción Muscular , Fibras Musculares Esqueléticas/patología , Atrofia Muscular/genética , Atrofia Muscular/patología , Degeneración Nerviosa/patología , Degeneración Nerviosa/fisiopatología , Proteínas del Tejido Nervioso/genética , Proteínas del Tejido Nervioso/metabolismo , Neuropilina-1 , Nervios Periféricos/patología , Regiones Promotoras Genéticas , Proteínas Tirosina Quinasas Receptoras/genética , Proteínas Tirosina Quinasas Receptoras/metabolismo , Receptores de Factores de Crecimiento/genética , Receptores de Factores de Crecimiento/metabolismo , Receptores de Factores de Crecimiento Endotelial Vascular , Eliminación de Secuencia , Médula Espinal/fisiología , Factor A de Crecimiento Endotelial Vascular , Factores de Crecimiento Endotelial Vascular
5.
Acta Chir Belg ; 113(4): 304-7, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24224444

RESUMEN

Fibromatosis or desmoid tumour of the breast is an extremely rare, locally aggressive tumour with a tendency to relapse. Nevertheless these tumours do not have metastatic potential. Early recognition and wide local excision of the tumour is the treatment of choice. We present a case of a desmoid tumour of the breast in a 67-year-old woman and provide a review of the literature.


Asunto(s)
Neoplasias de la Mama/diagnóstico , Diagnóstico Precoz , Fibromatosis Agresiva/diagnóstico , Anciano , Neoplasias de la Mama/cirugía , Diagnóstico Diferencial , Femenino , Fibromatosis Agresiva/cirugía , Humanos , Imagen por Resonancia Magnética/métodos , Mastectomía , Recurrencia Local de Neoplasia , Ultrasonografía Mamaria/métodos
6.
B-ENT ; 9(2): 157-60, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23909123

RESUMEN

BACKGROUND: Extracranial meningiomas are common tumours but may occur in unexpected locations. Awareness can avoid misdiagnosis and inappropriate management of these tumours. We report the case of a 54-year-old Caucasian male with en plaque meningioma of the external ear canal and an intracranial temporal lobe meningioma. INTERVENTION: The patient underwent extended canal wall down atticomastoidectomy with preservation of the ossicular chain and tympanic membrane and en bloc resection of the bony posterior canal wall, tumour, and overlying skin. RESULTS: Radical removal of a grade I meningothelial meningioma was achieved. The tegmen tympani and dura were not breached. No connection with the temporal lobe meningioma was demonstrated. The patient recovered completely and experienced a marked improvement in hearing. No clinical signs of recurrent or residual tumour have occurred. CONCLUSION: Careful clinical examination and extensive radiological workup is required to avoid missing the unusual diagnosis of concurrent meningioma of the temporal bone and temporal lobe, and miss the chance to treat this disease adequately.


Asunto(s)
Neoplasias Encefálicas/diagnóstico , Neoplasias del Oído/diagnóstico , Meningioma/diagnóstico , Neoplasias Primarias Múltiples/diagnóstico , Neoplasias Encefálicas/cirugía , Conducto Auditivo Externo , Neoplasias del Oído/cirugía , Humanos , Imagen por Resonancia Magnética , Masculino , Meningioma/cirugía , Persona de Mediana Edad , Neoplasias Primarias Múltiples/cirugía , Lóbulo Temporal
7.
Eur J Vasc Endovasc Surg ; 42(1): 120-6, 2011 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-21524926

RESUMEN

OBJECTIVE: In this histological study, the role of the intraluminal blood during endovenous laser ablation was assessed. METHODS: In 12 goats, 24 lateral saphenous veins were treated with a 1500-nm diode laser. Four goats were treated in an anti-Trendelenburg position (group 1). The next four goats were treated in a Trendelenburg position (group 2) and the remaining four goats in the Trendelenburg position with additional injection of tumescent liquid (group 3). Postoperatively, the veins were removed after 1 week and sent for histological examination. We measured the number of perforations. Vein wall necrosis and the perivenous tissue destruction were quantified using a graded scale. RESULTS: The 'calculated total vein wall destruction' was significantly higher in the third group (81.83%), as compared with groups one (61.25%) (p < 0.001) and two (65.92%) (p < 0.001). All three groups showed a significant difference in the perivenous tissue destruction scale (p < 0.001) with the lowest score occurring in the third group. Vein wall perforations were significantly more frequent in groups one and two as compared with the third group (T-test respectively p < 0.001, p = 0.02). CONCLUSION: A higher intraluminal blood volume results in reduced total vein wall destruction. Injection of tumescent liquid prevents the perivenous tissue destruction and minimises the number of perforations.


Asunto(s)
Volumen Sanguíneo , Terapia por Láser , Vena Safena/cirugía , Animales , Cabras , Inclinación de Cabeza , Inyecciones Intravenosas , Terapia por Láser/efectos adversos , Terapia por Láser/instrumentación , Láseres de Semiconductores , Necrosis , Vena Safena/patología , Cloruro de Sodio/administración & dosificación , Factores de Tiempo
8.
Acta Gastroenterol Belg ; 84(4): 675-677, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34965053

RESUMEN

A 63-year old female patient with a medical history of hypereosinophilic syndrome with neurological and pulmonary involvement presented for a routine follow-up. The patient was asymptomatic but a routine scheduled ultrasound showed a gallbladder polyp of 19mm. One month later this polyp had grown to 36 mm. On magnetic resonance imaging of the liver there was a suspicion of gallbladder cancer and for this reason cholecystectomy was performed. Pathology however showed eosinophilic infiltration. Serum analysis showed an increase in her eosinophil count. The diagnosis of hypereosinophilic syndrome with eosinophilic infiltration of the gallbladder was made. The dose of corticosteroids was augmented and she recovered completely post-operatively with no residual flares of other organ damage during follow up.


Asunto(s)
Vesícula Biliar , Síndrome Hipereosinofílico , Colecistectomía , Femenino , Humanos , Hígado , Imagen por Resonancia Magnética , Persona de Mediana Edad
9.
Med Sci Sports Exerc ; 53(9): 1911-1921, 2021 09 01.
Artículo en Inglés | MEDLINE | ID: mdl-33787532

RESUMEN

PURPOSE: The aims of this study were 1) to model the temporal profile of W' recovery after exhaustion, 2) to estimate the contribution of changing V˙O2 kinetics to this recovery, and 3) to examine associations with aerobic fitness and muscle fiber type (MFT) distribution. METHODS: Twenty-one men (age = 25 ± 2 yr, V˙O2peak = 54.4 ± 5.3 mL·min-1·kg-1) performed several constant load tests to determine critical power and W' followed by eight trials to quantify W' recovery. Each test consisted of two identical exhaustive work bouts (WB1 and WB2), separated by a variable recovery interval of 30, 60, 120, 180, 240, 300, 600, or 900 s. Gas exchange was measured and muscle biopsies were collected to determine MFT distribution. W' recovery was quantified as observed W' recovery (W'OBS), model-predicted W' recovery (W'BAL), and W' recovery corrected for changing V˙O2 kinetics (W'ADJ). W'OBS and W'ADJ were modeled using mono- and biexponential fitting. Root-mean-square error (RMSE) and Akaike information criterion (∆AICC) were used to evaluate the models' accuracy. RESULTS: The W'BAL model (τ = 524 ± 41 s) was associated with an RMSE of 18.6% in fitting W'OBS and underestimated W' recovery for all durations below 5 min (P < 0.002). Monoexponential modeling of W'OBS resulted in τ = 104 s with RMSE = 6.4%. Biexponential modeling of W'OBS resulted in τ1 = 11 s and τ2 = 256 s with RMSE = 1.7%. W'ADJ was 11% ± 1.5% lower than W'OBS (P < 0.001). ∆AICC scores favored the biexponential model for W'OBS, but not for W'ADJ. V˙O2peak (P = 0.009) but not MFT distribution (P = 0.303) was associated with W'OBS. CONCLUSION: We showed that W' recovery from exhaustion follows a two-phase exponential time course that is dependent on aerobic fitness. The appearance of a fast initial recovery phase was attributed to an enhanced aerobic energy provision resulting from changes in V˙O2 kinetics.


Asunto(s)
Ciclismo/fisiología , Ejercicio Físico/fisiología , Músculo Esquelético/fisiología , Consumo de Oxígeno/fisiología , Esfuerzo Físico/fisiología , Adulto , Prueba de Esfuerzo , Humanos , Cinética , Masculino , Modelos Biológicos , Adulto Joven
10.
Eur J Vasc Endovasc Surg ; 40(1): 110-6, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19854079

RESUMEN

OBJECTIVE: In this histological study, the lateral saphenous vein of the goat was treated using a laser fibre to which a tulip-shaped, self-expandable catheter had been fixed to achieve endovenous laser ablation (EVLA). The catheter centres the laser fibre in the vein preventing direct contact with the vein wall. This study aims to establish whether prevention of direct contact between the fibre tip and the vein wall prevents ulceration and perforation of the vein wall and perivenous tissue destruction. MATERIALS AND METHODS: Ten lateral saphenous veins were treated, using the tulip catheter, in goats under general anaesthesia. Ten more veins were treated with a normal bare fibre. We used a 980 nm diode laser to provide the energy. Postoperatively the veins were removed immediately, at 10 days and after 3 weeks for histological examination. Destruction of the vessel wall was measured and perivenous tissue destruction was quantified using a graded scale. RESULTS: Ulceration and perforation were prevented when using the tulip catheter. It also achieved more even vein wall necrosis. Tulip-catheter-treated veins show a transmural vein wall necrosis in, on average, 80% of the total circumference compared to 64% in bare-fibre treated veins. Less perivenous tissue destruction was seen with the new catheter (perivenous tissue destruction scale: tulip catheter: 1.7 vs. bare fibre: 3.8). Three weeks after treatment, we found regression of the perivenous tissue destruction as the healing process continued. CONCLUSIONS: EVLA using the tulip catheter avoids ulceration and perforation of the vein associated with treatment using a bare fibre. It also results in more even circumferential vein wall necrosis and less perivenous tissue destruction.


Asunto(s)
Terapia por Láser/instrumentación , Láseres de Semiconductores , Vena Safena/cirugía , Animales , Diseño de Equipo , Cabras , Terapia por Láser/efectos adversos , Láseres de Semiconductores/efectos adversos , Ensayo de Materiales , Necrosis , Vena Safena/lesiones , Vena Safena/patología , Factores de Tiempo , Úlcera Varicosa/etiología , Úlcera Varicosa/patología , Úlcera Varicosa/prevención & control
11.
J Pediatr Urol ; 16(1): 43.e1-43.e8, 2020 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-31810878

RESUMEN

INTRODUCTION: The androgen receptor (AR) plays an important role in the development of male genitalia, and impaired androgen signalling has been hypothesised to underlie congenital penile malformations (CPM) such as hypospadias. Previous studies exploring the role of AR expression in the development of CPM have yielded conflicting results. OBJECTIVES: To assess AR expression in human foreskin of boys/men born with hypospadias, buried penis versus controls. STUDY DESIGN: Foreskin samples of 428 boys and men undergoing primary penile surgery (198 controls, 197 hypospadias, and 33 buried penis) were collected between October 2013 and July 2018. AR staining was performed in all samples and semi-quantitatively scored by two researchers independently, using a modified quick score (mQuicks) that assesses the proportion and intensity of AR staining in smooth muscle fibres. RESULTS: The interobserver variability of the mQuicks had a high level of agreement for the total score, as well as for the subscores. Two phases of high AR expression were observed in all groups, the first following the postnatal gonadotropin surge (i.e., mini-puberty) and the second in (pre-) puberty. No differences in AR expression were found in hypospadias or buried penis cases as compared to controls matched for age at time of surgery. DISCUSSION: This study describes the physiological evolution in AR expression in the human foreskin of boys with CPM and explains the cause of the previously reported, conflicting results. Despite the very large cohort, the limitations of this study are the low number of cases younger than six months at the time of surgery and the lack of Tanner stages to correlate with the mQuicks in adolescents. CONCLUSIONS: The mQuicks is a straightforward and informative tool to semi-quantitatively assess AR expression in the dartos tissue. In this study, AR expression in human foreskin shows a bimodal distribution in boys with CMP and controls, following physiological androgen exposure. No statistically significant difference in AR expression could be found between both groups. Whether other local mechanisms are affected by these physiological changes is currently unclear. However, strict age-matching should be considered when exploring the mechanisms underlying disturbed penile and urethral development in CMP.


Asunto(s)
Prepucio/anomalías , Prepucio/metabolismo , Hipospadias/etiología , Receptores Androgénicos/biosíntesis , Niño , Preescolar , Correlación de Datos , Humanos , Lactante , Masculino , Estudios Prospectivos , Receptores Androgénicos/fisiología
12.
Science ; 293(5534): 1491-5, 2001 Aug 24.
Artículo en Inglés | MEDLINE | ID: mdl-11520988

RESUMEN

beta-Amyloid plaques and neurofibrillary tangles (NFTs) are the defining neuropathological hallmarks of Alzheimer's disease, but their pathophysiological relation is unclear. Injection of beta-amyloid Abeta42 fibrils into the brains of P301L mutant tau transgenic mice caused fivefold increases in the numbers of NFTs in cell bodies within the amygdala from where neurons project to the injection sites. Gallyas silver impregnation identified NFTs that contained tau phosphorylated at serine 212/threonine 214 and serine 422. NFTs were composed of twisted filaments and occurred in 6-month-old mice as early as 18 days after Abeta42 injections. Our data support the hypothesis that Abeta42 fibrils can accelerate NFT formation in vivo.


Asunto(s)
Enfermedad de Alzheimer/patología , Amígdala del Cerebelo/patología , Péptidos beta-Amiloides/metabolismo , Encéfalo/patología , Ovillos Neurofibrilares/metabolismo , Fragmentos de Péptidos/metabolismo , Placa Amiloide/metabolismo , Proteínas tau/metabolismo , Anciano , Anciano de 80 o más Años , Enfermedad de Alzheimer/metabolismo , Péptidos beta-Amiloides/administración & dosificación , Animales , Epítopos , Femenino , Técnica del Anticuerpo Fluorescente , Humanos , Masculino , Ratones , Ratones Transgénicos , Microscopía Inmunoelectrónica , Mutación , Ovillos Neurofibrilares/patología , Fragmentos de Péptidos/administración & dosificación , Fosforilación , Placa Amiloide/patología , Conformación Proteica , Isoformas de Proteínas , Caracteres Sexuales , Proteínas tau/química , Proteínas tau/genética , Proteínas tau/inmunología
13.
Am J Transplant ; 8(4): 877-80, 2008 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-18261173

RESUMEN

A 69-year-old man, with a history of end-stage renal disease due to polyarteritis nodosa, followed by invasive pulmonary aspergillosis secondary to cyclophosphamide and corticosteroids, received a renal transplant 2 years ago under prophylactic treatment with voriconazole. Because of the severity of the aspergillosis, it was decided to continue voriconazole for a prolonged period. Eighteen months after transplantation, the patient developed a severe facial phototoxic reaction. A few months later, he developed multiple actinic keratoses and a large, rapidly expanding, poorly differentiated squamous cell carcinoma (SCC) with perineural invasion and metastatic lymph nodes, necessitating radical surgery and radiotherapy. Voriconazole therapy has been suggested to be involved in the development of multi-focal invasive SCC when complicated by a phototoxic reaction. Therefore, an alternative antifungal prophylaxis regimen (for instance with posaconazole) should be considered when evaluating patients for solid organ transplantation who are at high risk for the development of cutaneous malignancies.


Asunto(s)
Antifúngicos/efectos adversos , Carcinoma de Células Escamosas/cirugía , Trasplante de Riñón , Pirimidinas/efectos adversos , Neoplasias Cutáneas/cirugía , Triazoles/efectos adversos , Anciano , Aspergilosis/complicaciones , Aspergilosis/tratamiento farmacológico , Carcinoma de Células Escamosas/inducido químicamente , Carcinoma de Células Escamosas/patología , Humanos , Fallo Renal Crónico/complicaciones , Fallo Renal Crónico/cirugía , Metástasis Linfática , Masculino , Invasividad Neoplásica , Complicaciones Posoperatorias , Neoplasias Cutáneas/inducido químicamente , Neoplasias Cutáneas/patología , Voriconazol
14.
Acta Neurochir (Wien) ; 150(11): 1183-91, 2008 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-18936876

RESUMEN

BACKGROUND: Chordoid glioma is a rare tumour (World Health Organisation grade II) originating from the third ventricle with both glial and chordoid features. It was first described by Brat in 1998. Since there is no detailed information available on the outcome after surgery and adjuvant treatment, we reviewed the literature. METHODS: A literature search through PUBMED revealed 50 cases of chordoid glioma. Most reports were found in pathology journals. Information on the postoperative course was sometimes very limited. We reviewed the available literature and studied in detail the presenting symptoms, mortality and postoperative complications in relation to the extent of resective surgery, as well as the importance of adjuvant treatment. CONCLUSIONS: Mortality in the immediate postoperative period is 32% and is higher after gross total resection as compared to subtotal resection. Non-fatal postoperative complications are hypothalamic disorders and mental alterations. Gross total resection is the treatment of choice since no recurrence has been reported after macroscopically complete resection, but this is often difficult because of the location and adherence to the hypothalamus. The role of postoperative radiotherapy is uncertain. There is some indication that radiosurgery with or without conventional irradiation is superior to conventional radiation alone. Planned subtotal resection followed by stereotactic radiosurgery can be a safe and effective alternative in a patient in whom gross total resection is considered to be too risky. There is no report on the use of chemotherapy in the treatment of chordoid gliomas. More information about the optimal treatment strategy is needed, and more reports are also needed.


Asunto(s)
Neoplasias del Ventrículo Cerebral/patología , Neoplasias del Ventrículo Cerebral/cirugía , Glioma/patología , Glioma/cirugía , Tercer Ventrículo/patología , Neoplasias del Ventrículo Cerebral/complicaciones , Femenino , Glioma/complicaciones , Humanos , Enfermedades Hipotalámicas/etiología , Enfermedades Hipotalámicas/patología , Enfermedades Hipotalámicas/fisiopatología , Masculino , Invasividad Neoplásica/patología , Invasividad Neoplásica/fisiopatología , Procedimientos Neuroquirúrgicos/efectos adversos , Procedimientos Neuroquirúrgicos/métodos , Procedimientos Neuroquirúrgicos/mortalidad , Complicaciones Posoperatorias/mortalidad , Complicaciones Posoperatorias/fisiopatología , Radiocirugia/métodos , Radiocirugia/normas , Distribución por Sexo , Tercer Ventrículo/fisiopatología , Tercer Ventrículo/cirugía
15.
Clin Microbiol Infect ; 24(12): 1328-1332, 2018 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-29559392

RESUMEN

OBJECTIVES: Sexually transmitted infections (STIs) are a global cause of acute illness. Early detection plays a crucial role in interrupting transmission and preventing complications. However, the accessibility of STI testing is curbed by the lack of an overall preferred sample type. By means of a prospective study in female sex workers (FSW), we compared the sensitivity of samples from different anatomical sites in detecting Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis, Mycoplasma genitalium and human papillomavirus. Besides, we documented the prevalence of each STI in this high-risk population. METHODS: We selected 303 FSW and tested them for each STI by nucleic acid amplification testing on two vaginal and cervical swabs from different manufacturers, cervical smear and first-void urine. The sensitivity of each sample type was compared for each infectious agent in order to identify a consensus sample type. RESULTS: Vaginal swabs were superior to all other sample types, with an overall sensitivity of 86%. The sensitivity was the lowest for first-void urine, detecting only 63% of positive cases. The prevalence was 3.3% (10/299) for Neisseria gonorrhoeae; 9.0% (27/299) for Chlamydia trachomatis; 7.4% (22/298) for Trichomonas vaginalis; 10.8% (32/296) for Mycoplasma genitalium and 55.6% (158/284) for human papillomavirus. CONCLUSIONS: When testing for STIs, vaginal swabs are the sample of choice and first-void urine should be avoided. Designating (self-sampled) vaginal swabs as a consensus sample type enables harmonization of STI testing and extension of testing to large numbers of unscreened females.


Asunto(s)
Infecciones por Chlamydia/diagnóstico , Gonorrea/diagnóstico , Infecciones por Mycoplasma/diagnóstico , Infecciones por Papillomavirus/diagnóstico , Enfermedades de Transmisión Sexual/diagnóstico , Vaginitis por Trichomonas/diagnóstico , Adolescente , Adulto , Bélgica/epidemiología , Infecciones por Chlamydia/microbiología , Chlamydia trachomatis/genética , Chlamydia trachomatis/aislamiento & purificación , Consenso , Femenino , Gonorrea/microbiología , Humanos , Persona de Mediana Edad , Infecciones por Mycoplasma/microbiología , Mycoplasma genitalium/genética , Mycoplasma genitalium/aislamiento & purificación , Neisseria gonorrhoeae/genética , Neisseria gonorrhoeae/aislamiento & purificación , Técnicas de Amplificación de Ácido Nucleico , Papillomaviridae/genética , Papillomaviridae/aislamiento & purificación , Infecciones por Papillomavirus/virología , Prevalencia , Estudios Prospectivos , Enfermedades de Transmisión Sexual/epidemiología , Enfermedades de Transmisión Sexual/microbiología , Enfermedades de Transmisión Sexual/virología , Manejo de Especímenes/métodos , Vaginitis por Trichomonas/microbiología , Trichomonas vaginalis/genética , Trichomonas vaginalis/aislamiento & purificación , Vagina/microbiología , Vagina/virología , Frotis Vaginal , Adulto Joven
16.
Biochem Soc Symp ; (67): 203-10, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11447836

RESUMEN

We have reported transgenic mice with neuronal overexpression of the clinical mutant beta-amyloid precursor protein (APP) known as London, which develop an AD-related phenotype [Moechers, Dewachter, Lorent, Reversé, Baekelandt, Nadiu, Tesseur, Spittaels, Van den Haute, Checler, et al. (1999) J. Biol. Chem. 274, 6483-6492]. Characterized early symptoms (3-9 months) include disturbed behaviour, neophobia, aggression, hypersensitivity to kainic acid, hyposensitivity to N-methyl-D-aspartate, defective cognition and memory, and decreased long-term potentiation. Late in life, at 12-15 months, amyloid plaques develop in the brain and correlate with increased levels of beta-amyloid (A beta)40/42 (the 40- and 42-amino-acid forms of A beta). The formation of amyloid plaques is dissociated in time from and not involved in the early phenotype. Hyperphosphorylated protein tau is present but no tangle pathology is observed. In double-transgenic mice, i.e. APP/London x Presenilin 1, the increased production of A beta 42 results in amyloid plaques developing by the age of 6 months. Transgenic mice with overexpression of either human apolipoprotein E4 (ApoE4) or human protein tau in central neurons develop severe axonopathy in the brain and spinal cord. Progressive degeneration of nerves and muscles is demonstrated by motor problems, wasting and premature death. Tau is hyperphosphorylated but there is no formation of filaments or neurofibrillary tangles. The tangle aspect of AD pathology is still missing from all current transgenic amyloid models. Its implementation will require insight into the cellular signalling pathways which regulate the microtubule-stabilizing function by phosphorylation of neuronal tau.


Asunto(s)
Enfermedad de Alzheimer/genética , Enfermedad de Alzheimer/etiología , Precursor de Proteína beta-Amiloide/genética , Animales , Apolipoproteína E4 , Apolipoproteínas E/genética , Modelos Animales de Enfermedad , Humanos , Proteínas de la Membrana/genética , Ratones , Ratones Transgénicos , Mutación , Degeneración Nerviosa/etiología , Degeneración Nerviosa/genética , Presenilina-1 , Proteínas tau/genética
17.
Am J Surg Pathol ; 21(9): 1090-5, 1997 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-9298886

RESUMEN

Benign peripheral nerve tumors with a mesenchymal component are rare and are represented principally by the neuromuscular choristoma. We describe an 11-month-old male infant who presented with a mass arising from the left brachial plexus. The lesion was bound firmly to the involved nerves and consisted histologically and ultrastructurally of bundles of well-differentiated smooth muscle cells intermingled with striated muscle fibers and unmyelinated nerve fibers. In the 13 previously published cases of neuromuscular choristoma, no smooth muscle component was observed. This unique peripheral nerve choristoma with not only striated but also smooth muscle closely resembled neuromuscular choristoma and was considered a variant of it.


Asunto(s)
Hamartoma/patología , Músculo Esquelético/patología , Músculo Liso/patología , Enfermedades Neuromusculares/patología , Plexo Braquial , Desmina/análisis , Desmina/metabolismo , Hamartoma/química , Humanos , Inmunohistoquímica , Lactante , Masculino , Microscopía Electrónica , Músculo Esquelético/química , Músculo Liso/química , Fibras Nerviosas/ultraestructura , Enfermedades Neuromusculares/metabolismo , Proteínas S100/análisis , Proteínas S100/metabolismo , Células de Schwann/química , Células de Schwann/patología , Tomografía Computarizada por Rayos X
18.
Am J Surg Pathol ; 23(3): 329-35, 1999 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-10078925

RESUMEN

Calcifying fibrous pseudotumor is a recently described distinctive lesion, characterized by the presence of abundant hyalinized collagen with psammomatous or dystrophic calcifications and a lymphoplasmacytic infiltrate. The cause and pathogenesis are unclear, but a possible relationship with other pseudotumors, like nodular fasciitis or inflammatory myofibroblastic tumor, has been proposed by some authors. However, cases with overlapping histologic features have not been reported. A 17-year-old girl with multiple peritoneal calcifying fibrous pseudotumors and inflammatory myofibroblastic tumors (inflammatory pseudotumors) is described. Some multinodular lesions showed calcifying fibrous pseudotumors next to inflammatory myofibroblastic tumors. Transitional stages between calcifying fibrous pseudotumor and inflammatory myofibroblastic tumor were also present. This case clearly illustrates a histogenetic relationship between calcifying fibrous pseudotumor and inflammatory myofibroblastic tumor, and it suggests that calcifying fibrous pseudotumor is a late sclerosing stage of inflammatory myofibroblastic tumor, at least in some cases.


Asunto(s)
Calcinosis/patología , Granuloma de Células Plasmáticas/patología , Enfermedades Peritoneales/patología , Adolescente , Calcinosis/cirugía , Femenino , Granuloma de Células Plasmáticas/cirugía , Humanos , Enfermedades Peritoneales/cirugía , Terminología como Asunto
19.
Neuroscience ; 113(4): 797-808, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12182887

RESUMEN

Glycogen synthase kinase-3beta (GSK-3beta) is important in neurogenesis. Here we demonstrate that the kinase influenced post-natal maturation and differentiation of neurons in vivo in transgenic mice that overexpress a constitutively active GSK-3beta[S9A]. Magnetic resonance imaging revealed a reduced volume of the entire brain, concordant with a nearly 20% reduction in wet brain weight. The reduced volume was most prominent for the cerebral cortex, without however, disturbing the normal cortical layering. The resulting compacted architecture was further demonstrated by an increased neuronal density, by reduced size of neuronal cell bodies and of the somatodendritic compartment of pyramidal neurons in the cortex. No evidence for apoptosis was obtained. The marked overall reduction in the level of the microtubule-associated protein 2 in brain and in spinal cord, did not affect the ultrastructure of the microtubular cytoskeleton in the proximal apical dendrites. The overall reduction in size of the entire CNS induced by constitutive active GSK-3beta caused only very subtle changes in the psychomotoric ability of adult and ageing GSK-3beta transgenic mice.


Asunto(s)
Encéfalo/enzimología , Encéfalo/patología , Glucógeno Sintasa Quinasa 3/biosíntesis , Neuronas/enzimología , Neuronas/patología , Animales , Animales Recién Nacidos , Encéfalo/crecimiento & desarrollo , Femenino , Glucógeno Sintasa Quinasa 3/genética , Humanos , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Desempeño Psicomotor/fisiología
20.
Exp Gerontol ; 35(6-7): 831-41, 2000 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-11053674

RESUMEN

In transgenic mice that overexpress mutant Amyloid Precursor Protein [V717I], or APP/London (APP/Lo) (1999a. Early phenotypic changes in transgenic mice that overexpress different mutants of Amyloid Precursor Protein in brain. J. Biol. Chem. 274, 6483-6492; 1999b. Premature death in transgenic mice that overexpress mutant Amyloid precursor protein is preceded by severe neurodegeneration and apoptosis. Neuroscience 91, 819-830) the AD related phenotype of plaque and vascular amyloid pathology is late (12-15 months). This typical and diagnostic pathology is thereby dissociated in time from early symptoms (3-9 months) that include disturbed behavior, neophobia, aggression, glutamate excitotoxicity, defective cognition and decreased LTP. The APP/Lo transgenic mice are therefore a very interesting model to study early as well as late pathology, including the effect of age. In ageing APP*Lo mice, brain soluble and especially "insoluble" amyloid peptides dramatically increased, while normalized levels of secreted APPsalpha and APPsbeta, as well as cell-bound beta-C-stubs, remained remarkably constant, indicating normal alpha- and beta-secretase processing of APP. In double transgenic mice, i.e. APP/LoxPS1, clinical mutant PS1[A246E] but not wild-type human PS1 increased Abeta, and plaques and vascular amyloid developed at age 6-9 months. The PS1 mutant caused increasing Abeta42 production, while ageing did not. Amyloid deposits are thus formed, not by overproduction of Abeta, but by lack of clearance and/or degradation in the brain of ageing APP/Lo transgenic mice. The clearance pathways of the cerebral amyloid peptides are therefore valuable targets for fundamental research and for therapeutic potential. Although hyper-phosphorylated protein tau was evident in swollen neurites around the amyloid plaques, neurofibrillary pathology is not observed and the "tangle" aspect of AD pathology is therefore still missing from all current transgenic "amyloid" models. Also the "ApoE4" risk for late onset AD remains a problem for modeling in transgenic mice. We have generated transgenic mice that overexpress human ApoE4 (2000. Expression of Human Apolipoprotein E4 in neurons causes hyperphosphorylation of Protein tau in the brains of transgenic mice. Am. J. Pathol. 156 (3) 951-964) or human protein tau (1999. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. Am. J. Pathol. 155, 2153-2165) in their neurons. Both develop a similar although not identical axonopathy, with progressive degeneration of nerves and with muscle wasting resulting in motoric problems. Remarkably, ApoE4 transgenic mice are, like the tau transgenic mice, characterized by progressive hyper-phosphorylation of protein tau also in motor neurons which explains the motoric defects. Further crossing with the APP/Lo transgenic mice is ongoing to yield "multiple" transgenic mouse strains to study new aspects of amyloid and tau pathology.


Asunto(s)
Envejecimiento , Enfermedad de Alzheimer/etiología , Precursor de Proteína beta-Amiloide/fisiología , Modelos Animales de Enfermedad , Proteínas de la Membrana/fisiología , Animales , Apolipoproteína E4 , Apolipoproteínas E/fisiología , Humanos , Ratones , Ratones Transgénicos , Presenilina-1 , Proteínas tau/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA